Suptavumab
Based on 1 Customer Validation
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : ≥95.0%
- CAS No.: 1629615-23-1
- Masse moléculaire:145.8 kDa
-
Stockage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-P99804
ClesrovimabAnti-RSV Monoclonal Antibody -
HY-P9944
PalivizumabRSV Inhibitor -
HY-P99756
NirsevimabAnti-RSV Antibody -
HY-P99209
MotavizumabAnti-RSV mAb -
HY-109142
ZiresovirRSV F Inhibitor -
HY-16727
PresatovirRSV Fusion Inhibitor -
HY-12983
ALS-8112 -
HY-12993
RSV604RSV Replication Inhibitor -
HY-12983A
LumicitabineRSV Polymerase Inhibitor -
HY-123475
SisunatovirRSV-F Protein Inhibitor -
HY-120632
BMS-433771RSV Inhibitor -
HY-102038
PC786RSV Inhibitor
Activité biologique
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Virus
IC50 & Target
RSV-F
In Vitro
Accession
A0A0X8XRK2
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
Application
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 1629615-23-1
-
Appearance Liquid
-
Masse moléculaire 145.8 kDa
-
Color Colorless to light yellow
-
SMILES
[Suptavumab]
-
Synonyms
REGN2222
-
Livraison
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
Fiche technique (256 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Références
[1]. Simões EAF, et al. Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants. Clin Infect Dis. 2021 Dec 6;73(11):e4400-e4408. [Content Brief]
[2]. Rodriguez-Fernandez R, et al. Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Infection. Pediatr Infect Dis J. 2021 May 1;40(5S):S35-S39. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Suptavumab Related Classifications
HY-P99586 Related Classifications
Powered by Bioz